InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -17.57% |
| Q3 2025 | -12.21% |
| Q2 2025 | 60.62% |
| Q1 2025 | 8.08% |
| Q4 2024 | -13.91% |
| Q3 2024 | -12.17% |
| Q2 2024 | -10.80% |
| Q1 2024 | -10.35% |
| Q4 2023 | 36.77% |
| Q3 2023 | -20.89% |
| Q2 2023 | -6.20% |
| Q1 2023 | -12.37% |
| Q4 2022 | 13.71% |
| Q3 2022 | 21.43% |
| Q2 2022 | -14.91% |
| Q1 2022 | -21.68% |
| Q4 2021 | 12.52% |
| Q3 2021 | 81.49% |
| Q2 2021 | -22.00% |
| Q1 2021 | 3.39% |
| Q4 2020 | 127.15% |
| Q3 2020 | -15.37% |
| Q2 2020 | -7.43% |
| Q1 2020 | -22.04% |
| Q4 2019 | -15.12% |
| Q3 2019 | -15.50% |
| Q2 2019 | -9.95% |
| Q1 2019 | -7.47% |
| Q4 2018 | -11.16% |
| Q3 2018 | -4.57% |
| Q2 2018 | 79.70% |
| Q1 2018 | 1.71% |
| Q4 2017 | 90.91% |
| Q3 2017 | -4.60% |
| Q2 2017 | 92.18% |
| Q1 2017 | 100.12% |
| Q4 2016 | 31.73% |
| Q3 2016 | -0.90% |
| Q2 2016 | 11.03% |
| Q1 2016 | 4.90% |